Cargando…
Recent Application of Advanced MR Imaging to Predict Pseudoprogression in High-grade Glioma Patients
Pseudoprogression is regarded as a subacute form of treatment-related change with a reported incidence of 20–30%, occurring predominantly within the first three months after the completion of concurrent chemoradiotherapy (CCRT) in glioblastoma multiforme (GBM) patients. Occurrence of progressive les...
Autores principales: | YOO, Roh-EUL, CHOI, Seung Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society for Magnetic Resonance in Medicine
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600053/ https://www.ncbi.nlm.nih.gov/pubmed/26726012 http://dx.doi.org/10.2463/mrms.rev.2015-0053 |
Ejemplares similares
-
Radiomics for pseudoprogression prediction in high grade gliomas: added value of MR contrast agent
por: Mammadov, Orkhan, et al.
Publicado: (2022) -
Pseudoprogression in low-grade glioma
por: Slater, Jason M., et al.
Publicado: (2019) -
Deep learning based on dynamic susceptibility contrast MR imaging for prediction of local progression in adult-type diffuse glioma (grade 4)
por: Heo, Donggeon, et al.
Publicado: (2023) -
Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis
por: Abbasi, Abdul W., et al.
Publicado: (2017) -
Neutrophil–lymphocyte ratio dynamics are useful for distinguishing between recurrence and pseudoprogression in high-grade gliomas
por: Huang, Yong, et al.
Publicado: (2019)